Corporate Statement

Mallinckrodt Pharmaceuticals is a multibillion dollar specialty pharmaceutical company focused on our mission: Listening for Needs. Delivering Solutions. We provide medicines to address unmet patient needs, stemming from 150 years of using our unique strengths, experience and expertise to help improve people’s lives. Discover how our rich history of innovation and patient-centered solutions has helped influence our vision for the future.

Investor Overview

News Releases

01 Aug '24
DUBLIN , Aug. 1, 2024 /PRNewswire/ -- Mallinckrodt plc  ("Mallinckrodt" or the "Company"), a global specialty pharmaceutical company, today announced that it will report second quarter 2024 earnings results for the period ended June 28, 2024, on Tuesday, August 6, 2024 .      A conference call for
05 Jun '24
– Three posters highlight  research on outcomes of TERLIVAZ treatment in key subpopulations of adults with HRS with rapid reduction in kidney function 1  – DUBLIN , June 5, 2024 /PRNewswire/ -- Mallinckrodt plc , a global specialty pharmaceutical company, today announced the presentation of three
go back to the top of the page